Planning Approval Sample Clauses

Planning Approval. The Borrower shall ensure that the planning approval obtained from the relevant government authority for the Project be current and valid at all material times;
AutoNDA by SimpleDocs
Planning Approval. The Owner shall obtain any required planning approval at its expense unless the word ‘Builder’ is written on this dotted line:……………………, in which case the Builder shall obtain the required planning approval at its expense.
Planning Approval. 9.1 The Property is one of the building plots comprised in a section of the Housing Estate intended to be developed *as Phase , the layout of which has been approved by the Competent Authority and the Commissioner of Building Control.
Planning Approval. 4.1.1 The Project Co shall use all reasonable endeavours to obtain any Planning Approval.
Planning Approval. On 29 August 2007, the NSW Minister for Planning granted Project Approval for the Glenfield Junction Works of the SWRL (Stage A) and Concept Approval for the remainder of the SWRL. This followed the exhibition of the Concept Plan Environmental Assessment and preparation of a Submissions Report in late 2006 and early 2007. The Concept Plan approval was subject to a number of control measures and further requirements for environmental impact assessments for the SWRL. To progress with the design and further assessment of the SWRL, the project has been split into stages for planning approval with separate environmental assessment requirements for each. It is expected that the Alliance will ensure that required information is made available to the TIDC Planning Approvals Consultant to assist in preparation of the environmental assessments for the project as described in the below. Glenfield Transport Interchange (GTI) Stage A: Glenfield Junction Works (including the Glenfield flyover and the establishment of associated temporary construction sites) Project Approval has been granted for this stage of the project as sufficient assessment was undertaken during the preparation of the EA and Concept Plan and Submissions Report. Project Approval was granted subject to a number of conditions, including the requirement to prepare a detailed Construction Environmental Management Plan (CEMP) prior to construction commencing. This CEMP will include Noise and Vibration, Traffic and Flora and Fauna Management measures. No additional environmental assessment or planning approvals are required for this part of the project. Stage B1: Glenfield Station and Interchange A Review of Environmental Factors (REF) is currently being prepared for the these works in accordance with the requirements of Part 5 of the Environmental Planning and Assessment Xxx 0000 (EP&A Act). The REF focuses on the further design and assessment of: • The new Glenfield Station building, facilities and a new concourse bicycle/pedestrian facilities and ‘easy access’ (including lifts) at Glenfield Station; • The new transport interchange including bus facilities, kiss-and-ride facilities, taxi zonesand improved pedestrian and cyclist access to the station; • Roadworks, landscape and urban design works along Railway Parade and Xxx Xxxxx Road • The relocation of car spaces on Railway Parade & Xxx Xxxxx Road to a new multi-storey commuter car park of approximately 700 car spaces on the western side of Glenfield S...
Planning Approval. SAFETY DURING CONSTRUCTION In this Section 2 (Safety During Construction) of Schedule Part 5 (Construction Matters) and wherever used elsewhere in this Agreement:
Planning Approval. 14.1 To any extent that Planning Approval has not been given, the obtaining of Planning Approval and where and when it has been given compliance with its terms is an obligation under the Contract to be discharged by the Contractor.
AutoNDA by SimpleDocs
Planning Approval 

Related to Planning Approval

  • Regulatory Approval 25.1 The Parties understand and agree that this Agreement and any amendment or modification hereto will be filed with the Commission for approval in accordance with Section 252 of the Act and may thereafter be filed with the FCC. The Parties believe in good faith and agree that the services to be provided under this Agreement are in the public interest. Each Party covenants and agrees to fully support approval of this Agreement by the Commission or the FCC under Section 252 of the Act without modification.

  • Regulatory Approvals All Requisite Regulatory Approvals shall have been obtained and shall remain in full force and effect and all statutory waiting periods in respect thereof shall have expired, and no such Requisite Regulatory Approval shall have resulted in the imposition of any Materially Burdensome Regulatory Condition.

  • City Approval Wherever any approval or consent of the City, or of any of its departments, officials or employees, is called for under this Agreement, the same shall not be unreasonably withheld or delayed.

  • Project Approval The County may issue a Job Order Authorization for the Work, to include the firm-fixed-price of the Job Order and the project duration. Contractor agrees that all clauses of this Contract are applicable to any Job Order issued hereunder. The County reserves the right to reject a Contractor’s Quote based on unjustifiable quantities and/or methods, performance periods, inadequate documentation, or other inconsistencies or deficiencies on the Contractor’s part in the sole opinion of the County. The County reserves the right to issue a unilateral Job Order authorization for the Work if a Quote price cannot be mutually agreed upon. This is based upon unjustifiable quantities in the sole opinion of the County. The County also reserves the right to not issue a Job Order Authorization if the County’s requirement is no longer valid or the project is not funded. In these instances, the Contractor has no right of claim to recover Quote expenses. The County may pursue continuing valid requirements by other means where Contract was not reached with the Contractor.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

Time is Money Join Law Insider Premium to draft better contracts faster.